Oldehinkel et al. found that, apart from the primary functional connectivity gradient, a second axis of connectopic organization was present in the striatum that closely resembled the spatial distribution of dopamine transporters across different medication and symptomatology stages, providing a non-invasive marker for striatal dopamine transporter density in PD (Oldehinkel et al., 2022). Here, SLC6A3 is linked to Parkinson disease.